نتایج جستجو برای: nras

تعداد نتایج: 2055  

Journal: :Journal of synchrotron radiation 2014
P Skopintsev A Singer J Bach L Müller B Beyersdorff S Schleitzer O Gorobtsov A Shabalin R P Kurta D Dzhigaev O M Yefanov L Glaser A Sakdinawat G Grübel R Frömter H P Oepen J Viefhaus I A Vartanyants

A method to characterize the spatial coherence of soft X-ray radiation from a single diffraction pattern is presented. The technique is based on scattering from non-redundant arrays (NRAs) of slits and records the degree of spatial coherence at several relative separations from 1 to 15 µm, simultaneously. Using NRAs the spatial coherence of the X-ray beam at the XUV X-ray beamline P04 of the PE...

Journal: :Annals of Oncology 2023

RAS and BRAF genes are crucial therapeutic prognostic markers in metastatic colorectal cancer. Once activated, these oncogenes play a key role carcinogenesis from the beginning steps until metastasis development. Several hotspot mutations were described KRAS NRAS codon 600 of gene. Herein, we interested RAS/BRAF mutation profiles cancer compared to non-metastatic tumors. We screened for byt he ...

2016
Romi Gupta Matteo Forloni Malik Bisserier Shaillay Kumar Dogra Qiaohong Yang Narendra Wajapeyee

Mutations in the NRAS oncogene are present in up to 20% of melanoma. Here, we show that interferon alpha-inducible protein 6 (IFI6) is necessary for NRASQ61K-induced transformation and melanoma growth. IFI6 was transcriptionally upregulated by NRASQ61K, and knockdown of IFI6 resulted in DNA replication stress due to dysregulated DNA replication via E2F2. This stress consequentially inhibited ce...

Journal: :Blood 2012
Sayoko Doisaki Hideki Muramatsu Akira Shimada Yoshiyuki Takahashi Makiko Mori-Ezaki Masanori Sato Hiroyuki Kawaguchi Akitoshi Kinoshita Manabu Sotomatsu Yasuhide Hayashi Yoko Furukawa-Hibi Kiyofumi Yamada Hideaki Hoshino Hitoshi Kiyoi Nao Yoshida Hirotoshi Sakaguchi Atsushi Narita Xinan Wang Olfat Ismael Yinyan Xu Nobuhiro Nishio Makito Tanaka Asahito Hama Kenichi Koike Seiji Kojima

Juvenile myelomonocytic leukemia (JMML) is a rare pediatric myeloid neoplasm characterized by excessive proliferation of myelomonocytic cells. Somatic mutations in genes involved in GM-CSF signal transduction, such as NRAS, KRAS, PTPN11, NF1, and CBL, have been identified in more than 70% of children with JMML. In the present study, we report 2 patients with somatic mosaicism for oncogenic NRAS...

2014
Rodney Shackelford Maressa Pollen Moise Vora Tamara T. Jusion James Cotelingam Binu Nair

Cutaneous melanoma is an aggressive malignant tumor of melanocytes which accounts for 80% of skin cancer-related deaths. A number of driver mutations have been identified in melanoma, with the mutually exclusive BRAF V600E and NRAS Q61A mutations together accounting for roughly 70% of mutations. Simultaneous BRAF V600E and NRAS Q61A mutations in melanoma are rare, with evidence suggesting that ...

Journal: :Clinical chemistry and laboratory medicine 2016
Miriam Potrony Celia Badenas Bénédicte Naerhuyzen Paula Aguilera Joan Anton Puig-Butille Gemma Tell-Marti Alba Díaz Cristina Carrera Llucia Alos Nicolas Delahaye Josep Malvehy Susana Puig

BACKGROUND BRAF and NRAS mutation detection is crucial for advanced melanoma treatment. Our aim was to evaluate how different characteristics from formalin-fixed paraffin-embedded (FFPE) samples, age of the block or DNA concentration could influence the success of BRAF and NRAS mutational screening. METHODS DNA was obtained from 144 FFPE samples (62 primary melanoma, 43 sentinel lymph nodes [...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015
Nicolas Piton Etienne Lonchamp Frédérique Nowak Jean-Christophe Sabourin

In metastatic colorectal cancer, KRAS and NRAS genotyping is mandatory before prescription of panitumumab or cetuximab. In order to perform such molecular tests, the French National Cancer Institute has set up a nationwide network of molecular centers. We report here the percentage of these mutations according to a prospective nonselected cohort of incident metastatic colorectal carcinoma patie...

2016
Xin Gao Xiangxuan Liu Zuoming Zhu Xuanjun Wang Zheng Xie

Modified TiO2 nanomaterials are considered to be promising in energy conversion and ferrites modification may be one of the most efficient modifications. In this research, various ferrites, incorporated with various cations (MFe2O4, M = Ni, Co, Zn, and Sr), are utilized to modify the well aligned TiO2 nanorod arrays (NRAs), which is synthesized by hydrothermal method. It is found that all MFe2O...

Journal: :PLoS ONE 2009
Bijay S. Jaiswal Vasantharajan Janakiraman Noelyn M. Kljavin Jeffrey Eastham-Anderson James E. Cupp Yuxin Liang David P. Davis Klaus P. Hoeflich Somasekar Seshagiri

BACKGROUND Oncogenic RAS is a highly validated cancer target. Attempts at targeting RAS directly have so far not succeeded in the clinic. Understanding downstream RAS-effectors that mediate oncogenesis in a RAS mutant setting will help tailor treatments that use RAS-effector inhibitors either alone or in combination to target RAS-driven tumors. METHODOLOGY/PRINCIPAL FINDINGS In this study, we...

2016
Yinchen Shen Xiaohong Han Jianfei Wang Shuai Wang Hongying Yang Shih-Hsin Lu Yuankai Shi

Development of colorectal cancer (CRC) associates with accumulation of genetic mutations include the epidermal growth factor receptor (EGFR) signaling pathway. However, whether mutations in KRAS together with downstream factors BRAF, PIK3CA and NRAS impact prognosis is still unclear for stage II-III colon cancer. In the present study a total of 228 stage II-III colon cancer samples were retrosp...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید